QuickView for phosphatidylinositol 3-kinase complex, class III (biogroup)

1. The Immunological Genome Project - Immune cell lineage differentiation and maturation
2. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
3. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
5. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens

There were no matches for phosphatidylinositol 3-kinase complex, class III

1. Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care
2. Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas
3. A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma…
4. Addition of Everolimus to Standard of Care in Carcinoma Gallbladder
5. Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas…